If you think the Congressional panel is not going to look into the hows and whys of the FDA decision and how it was related to the two conflicted panel members, I predict you'll be wrong. Whether or not the decision gets reversed (odds are against it), I'm virtually certain it will at least be looked into.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.